Content & Research Process
Last reviewed: March 23, 2026
This page explains how War Against HS researches, evaluates, and maintains the health information published on this website. Our goal is to be transparent about our process so readers can assess the quality and basis of our content.
Purpose
War Against HS exists to provide people affected by Hidradenitis Suppurativa with accurate, accessible, and research-informed educational content. HS is a chronic inflammatory skin condition that is frequently misdiagnosed, undertreated, and poorly understood - even within the medical community. Patients and caregivers often struggle to find reliable information that reflects current scientific understanding.
Our purpose is to close that gap. We aim to translate peer-reviewed research, clinical guidelines, and expert consensus into clear, practical information that empowers patients to understand their condition, ask better questions, and engage more effectively with their healthcare providers.
What this page covers
- How we select and evaluate sources for our content
- The standards we apply when researching and writing articles
- How we distinguish educational information from medical advice
- How we monitor and update content as new evidence emerges
- How we maintain transparency about our sourcing and limitations
Research Standards
All content published on War Against HS is researched using credible, authoritative sources. We apply a hierarchy of evidence that prioritizes peer-reviewed research and established clinical guidelines over anecdotal reports or unverified claims. The following source categories form the foundation of our research process:
Peer-Reviewed Medical Journals
We prioritize studies published in indexed, peer-reviewed journals where findings have been evaluated by independent experts before publication.
- -Journal of the American Academy of Dermatology (JAAD)
- -British Journal of Dermatology
- -JAMA Dermatology
- -Dermatology and Therapy
- -Journal of Investigative Dermatology
Dermatology Organizations and Guidelines
Clinical practice guidelines from recognized dermatology bodies represent the current consensus of expert practitioners and inform how we describe treatment approaches.
- -American Academy of Dermatology (AAD)
- -European Academy of Dermatology and Venereology (EADV)
- -International Hidradenitis Suppurativa Research Group (IHRG)
- -North American Clinical Trials Network (HSCTN)
Academic and Clinical Publications
Systematic reviews, meta-analyses, and registered clinical trial results provide the strongest levels of evidence and are weighted accordingly in our content.
- -PubMed / MEDLINE indexed studies
- -Cochrane Systematic Reviews
- -ClinicalTrials.gov registered studies
- -University and academic medical center publications
Major Health Institutions
Regulatory and institutional sources provide authoritative information on approved treatments, drug safety, and official disease classifications.
- -U.S. Food and Drug Administration (FDA)
- -European Medicines Agency (EMA)
- -National Institutes of Health (NIH)
- -NIH Genetic and Rare Diseases Information Center (GARD)
- -Mayo Clinic and academic medical centers
Our Six-Step Review Process
Topic Identification
Topics are selected based on patient need, emerging research, and gaps in available HS educational resources.
Primary Source Research
Writers consult primary sources - original studies, clinical guidelines, and institutional publications - rather than relying on secondary summaries.
Cross-Reference Verification
Key claims are cross-referenced against multiple credible sources to confirm accuracy and identify any conflicting evidence.
Context and Limitations
Study methodology, patient population size, and limitations are considered before drawing conclusions from research findings.
Editorial Review
Content is reviewed for factual accuracy, appropriate sourcing, clarity, and alignment with our editorial standards before publication.
Ongoing Monitoring
Published content is monitored for new developments and updated when significant new evidence emerges.
Content Review Philosophy
Our content aims to reflect the current scientific understanding of Hidradenitis Suppurativa as accurately and responsibly as possible. We approach health information with the following principles:
| Principle | What This Means in Practice |
|---|---|
| Evidence first | Claims are grounded in published research, not speculation or unverified community reports |
| Honest uncertainty | When evidence is limited, preliminary, or conflicting, we say so clearly rather than overstating confidence |
| Context matters | Study findings are presented with relevant context, including sample size, study design, and limitations |
| No false certainty | We do not present emerging or preliminary findings as established fact, and we distinguish between approved treatments and investigational therapies |
| Not a substitute for care | Our content is designed to inform and educate, not to replace the individualized assessment of a qualified healthcare provider |
We recognize that medical knowledge evolves continuously. Content that was accurate at the time of publication may become outdated as new research emerges. We monitor the literature and update our content accordingly.
Distinguishing Education from Medical Advice
One of the most important distinctions on this website is the difference between educational health information and medical advice. Understanding this distinction helps readers use our content appropriately and safely.
Educational Information (What We Provide)
- General explanations of HS symptoms, stages, and disease progression
- Summaries of research on treatment options and their evidence base
- Lifestyle and management strategies supported by research
- Information to help patients prepare for healthcare appointments
- Overviews of clinical trials and emerging therapies
Medical Advice (What We Do Not Provide)
- xDiagnosis of your specific condition or symptoms
- xPersonalized treatment recommendations for your situation
- xGuidance on whether to start, stop, or change medications
- xInterpretation of your test results or imaging
- xAdvice that substitutes for evaluation by a licensed clinician
The information on this website is intended to help you become a more informed patient - not to replace the individualized care of a physician who knows your full medical history. Always bring questions raised by our content to your healthcare provider.
Source Verification
Accuracy requires more than finding a single supporting reference. When possible, we cross-reference key claims against multiple credible sources to confirm consistency and identify any conflicting evidence in the literature.
Our source verification approach includes:
- Primary source preference - we consult the original published study or guideline rather than relying on a secondary summary or news report of the research
- Multi-source cross-referencing - significant claims are checked against at least two independent credible sources where available
- Conflict identification - when sources disagree or evidence is mixed, we present the range of findings rather than selecting only the evidence that supports a single conclusion
- Recency weighting - more recent research is weighted appropriately, particularly in a fast-moving field like HS where treatment options have expanded significantly in recent years
- Institutional verification - for regulatory information (drug approvals, safety updates), we verify directly with the relevant regulatory body (FDA, EMA) rather than relying on third-party reports
Despite our verification efforts, we acknowledge that errors can occur. If you identify information that appears inaccurate or outdated, please contact us at [email protected] so we can review and correct it promptly.
Updates and Emerging Research
The science of Hidradenitis Suppurativa is advancing at a meaningful pace. New biologic therapies are entering clinical trials, existing treatments are receiving new regulatory approvals, and researchers are developing a deeper understanding of HS pathophysiology, genetics, and comorbidities. We take this progress seriously.
War Against HS actively monitors new research developments through the following channels:
- Regular monitoring of major dermatology journals and conference proceedings for new HS-related publications
- Tracking of FDA and EMA drug approval announcements, safety communications, and label updates relevant to HS treatment
- Review of ClinicalTrials.gov for new and updated HS study registrations and results postings
- Monitoring of AAD, EADV, and major dermatology organization communications for guideline updates
- Community feedback from readers who identify outdated or inaccurate information
When significant new evidence emerges that changes or contradicts previously published content, we update the affected pages and note the revision date. For minor updates (correcting a statistic, adding a new study reference), we may update content without a formal revision notice.
Content that has not been recently reviewed may not reflect the most current research. We display publication and revision dates on articles to help readers assess the currency of information. When in doubt, consult your healthcare provider for the most up-to-date guidance.
Transparency
We believe that transparency about our sources and process is essential to responsible health communication. Readers should be able to verify the information they find on this website, not simply take our word for it.
Our transparency commitments in practice:
- Citations and references - we provide citations and references to source material wherever possible so readers can access and review the original research themselves
- Direct links to sources - where source material is publicly accessible (PubMed abstracts, FDA announcements, open-access journals), we link directly to the original document
- Acknowledging limitations - we clearly note when evidence is limited, based on small studies, or when findings have not been replicated
- Distinguishing evidence levels - we differentiate between randomized controlled trial data, observational studies, case reports, and expert opinion, as these carry different levels of evidentiary weight
- Corrections disclosure - when significant factual errors are corrected, we note the correction on the affected page
- AI-assisted content - where AI tools assist in content drafting or illustration, this is noted and all AI-assisted content is reviewed for accuracy before publication
If you would like to review the sources underlying a specific article, look for the references section at the bottom of the page or contact us to request additional source information.
Medical Disclaimer Reminder
Important: Please Read Before Using This Website
The information provided on WarAgainstHS.com is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Hidradenitis Suppurativa is a complex medical condition that requires professional evaluation and individualized care.
- Always seek the guidance of a qualified physician or other licensed healthcare provider with any questions you have regarding a medical condition, medication, or treatment plan
- Never disregard professional medical advice or delay seeking treatment because of information you have read on this website
- In a medical emergency, call emergency services (911 in the United States) immediately
- The authors and publishers of this website are not responsible for any actions taken based on the information presented here
Our content and research process is designed to ensure that educational content is as accurate and responsibly presented as possible. However, no review process eliminates the fundamental distinction between general educational information and the individualized medical judgment of a licensed clinician who knows your specific situation. Please use this website as a starting point for understanding HS, not as a substitute for professional medical care.
Last reviewed: March 23, 2026